Vrije Universiteit Brussel
Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia.
2020
Elsene
Steun voor het onderzoeksproject: "Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia".